Assignee
ARBUTUS BIOPHARMA CORP
US·52 granted patents·65 pending applications·302 citations·filing 2013–2025
Top patents by PatentIndex Score
117 records- 0199US9682139B2Lipids and compositions for the delivery of therapeuticsARBUTUS BIOPHARMA CORP·Filed 2015·Granted Jun 20, 2017·46 cites·20 claims
- 0298US12016929B2Lipid formulations for delivery of therapeutic agentsARBUTUS BIOPHARMA CORP·Filed 2024·Granted Jun 25, 2024·5 cites·22 claims
- 0398US11786598B2Lipid formulations for delivery of therapeutic agentsARBUTUS BIOPHARMA CORP·Filed 2022·Granted Oct 17, 2023·7 cites·17 claims
- 0498US11718852B2Non-liposomal systems for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2021·Granted Aug 8, 2023·5 cites·32 claims
- 0598US11141378B2Lipid formulations for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2021·Granted Oct 12, 2021·42 cites·30 claims
- 0697US12129467B2Non-liposomal systems for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2024·Granted Oct 29, 2024·2 cites·24 claims
- 0797US11318098B2Liposomal apparatus and manufacturing methodsARBUTUS BIOPHARMA CORP·Filed 2021·Granted May 3, 2022·3 cites·30 claims
- 0897US11298320B2Liposomal apparatus and manufacturing methodsARBUTUS BIOPHARMA CORP·Filed 2021·Granted Apr 12, 2022·3 cites·30 claims
- 0997US9764036B2Lipids and compositions for the delivery of therapeuticsARBUTUS BIOPHARMA CORP·Filed 2015·Granted Sep 19, 2017·19 cites·22 claims
- 1097US9636301B2In vitro release assay for liposome encapsulated vincristineARBUTUS BIOPHARMA CORP·Filed 2013·Granted May 2, 2017·29 cites·15 claims
- 1196US10653780B2Amino lipids and methods for the delivery of nucleic acidsARBUTUS BIOPHARMA CORP·Filed 2015·Granted May 19, 2020·28 cites·20 claims
- 1296US10561732B2Trialkyl cationic lipids and methods of use thereofARBUTUS BIOPHARMA CORP·Filed 2016·Granted Feb 18, 2020·13 cites·9 claims
- 1396US10117941B2Lipids and compositions for the delivery of therapeuticsARBUTUS BIOPHARMA CORP·Filed 2017·Granted Nov 6, 2018·12 cites·14 claims
- 1495US11446383B2Lipid formulations for delivery of therapeutic agentsARBUTUS BIOPHARMA CORP·Filed 2018·Granted Sep 20, 2022·6 cites·17 claims
- 1595US11191849B2Compositions and methods for delivering messenger RNAARBUTUS BIOPHARMA CORP·Filed 2017·Granted Dec 7, 2021·10 cites·10 claims
- 1695US10821186B2Lipids and compositions for the delivery of therapeuticsARBUTUS BIOPHARMA CORP·Filed 2018·Granted Nov 3, 2020·4 cites·24 claims
- 1794US10053689B2Methods for increasing efficacy of lipid formulated siRNAARBUTUS BIOPHARMA CORP·Filed 2015·Granted Aug 21, 2018·7 cites·9 claims
- 1893US12453776B2Lipids and compositions for the delivery of therapeuticsARBUTUS BIOPHARMA CORP·Filed 2024·Granted Oct 28, 2025·0 cites·46 claims
- 1993US11077197B2Lipids and compositions for the delivery of therapeuticsARBUTUS BIOPHARMA CORP·Filed 2017·Granted Aug 3, 2021·3 cites·17 claims
- 2092US12043833B2Targeted compositionsARBUTUS BIOPHARMA CORP·Filed 2022·Granted Jul 23, 2024·1 cites·18 claims
- 2192US2024316206A1Novel lipid formulations for delivery of therapeutic agentsARBUTUS BIOPHARMA CORP·Filed 2024·Application pending·0 cites
- 2291US11427823B2Targeted compositionsARBUTUS BIOPHARMA CORP·Filed 2018·Granted Aug 30, 2022·5 cites·16 claims
- 2391US11420931B2Lipid containing formulationsARBUTUS BIOPHARMA CORP·Filed 2019·Granted Aug 23, 2022·2 cites·20 claims
- 2491US9814777B2Targeting lipidsARBUTUS BIOPHARMA CORP·Filed 2013·Granted Nov 14, 2017·8 cites·11 claims
- 2591US9707292B2Lipids and compositions for the delivery of therapeuticsARBUTUS BIOPHARMA CORP·Filed 2015·Granted Jul 18, 2017·5 cites·12 claims
- 2691US2025034571A1Non-liposomal systems for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2024·Application pending·0 cites
- 2790US10456473B2Lipid compositionsARBUTUS BIOPHARMA CORP·Filed 2017·Granted Oct 29, 2019·6 cites·8 claims
- 2889US12042541B2Lipids and compositions for the delivery of therapeuticsARBUTUS BIOPHARMA CORP·Filed 2023·Granted Jul 23, 2024·0 cites·23 claims
- 2989US10626393B2Delivering CRISPR therapeutics with lipid nanoparticlesARBUTUS BIOPHARMA CORP·Filed 2016·Granted Apr 21, 2020·6 cites·15 claims
- 3089US2024035030A1Non-liposomal systems for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2023·Application pending·0 cites
- 3188US2023381319A1Novel lipids and compositions for the delivery of therapeuticsARBUTUS BIOPHARMA CORP·Filed 2023·Application pending·0 cites
- 3288US2023372245A1Lipid formulations for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2023·Application pending·0 cites
- 3388US2024100166A1Novel lipid formulations for delivery of therapeutic agentsARBUTUS BIOPHARMA CORP·Filed 2023·Application pending·0 cites
- 3487US10953095B2Lipid compositionsARBUTUS BIOPHARMA CORP·Filed 2019·Granted Mar 23, 2021·1 cites·19 claims
- 3587US9895448B2Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic componentsARBUTUS BIOPHARMA CORP·Filed 2016·Granted Feb 20, 2018·5 cites·19 claims
- 3686US12023383B2Lipid compositionsARBUTUS BIOPHARMA CORP·Filed 2023·Granted Jul 2, 2024·0 cites·20 claims
- 3784US11395854B2Trialkyl cationic lipids and methods of use thereofARBUTUS BIOPHARMA CORP·Filed 2020·Granted Jul 26, 2022·1 cites·14 claims
- 3883US10415037B2Compositions and methods for silencing hepatitis B virus gene expressionARBUTUS BIOPHARMA CORP·Filed 2015·Granted Sep 17, 2019·7 cites·23 claims
- 3982US10358447B2Substituted 2-N-hydroxy-1,3-dioxo-1,2,3,4-tetrahydronaphthyridines, and methods of making and using sameARBUTUS BIOPHARMA CORP·Filed 2018·Granted Jul 23, 2019·3 cites·24 claims
- 4082US9694077B2Lipid compositionsARBUTUS BIOPHARMA CORP·Filed 2014·Granted Jul 4, 2017·3 cites·13 claims
- 4182US2025099594A1Targeted compositionsARBUTUS BIOPHARMA CORP·Filed 2024·Application pending·0 cites
- 4282US2023174459A1Lipid containing formulationsARBUTUS BIOPHARMA CORP·Filed 2022·Application pending·0 cites
- 4382US2025179496A1Targeted compositionsARBUTUS BIOPHARMA CORP·Filed 2024·Application pending·0 cites
- 4481US12083118B2Substituted 1,1′-biphenyl compounds, analogues thereof, and methods using sameARBUTUS BIOPHARMA CORP·Filed 2019·Granted Sep 10, 2024·2 cites·26 claims
- 4581US2024245784A1Targeted nucleic acid conjugate compositionsARBUTUS BIOPHARMA CORP·Filed 2024·Application pending·0 cites
- 4680US2023165973A1Compositions and methods for delivering messenger rnaARBUTUS BIOPHARMA CORP·Filed 2022·Application pending·0 cites
- 4779US2020268664A1Liposomal apparatus and manufacturing methodsARBUTUS BIOPHARMA CORP·Filed 2019·Application pending·0 cites
- 4878US11712476B2Lipids and compositions for the delivery of therapeuticsARBUTUS BIOPHARMA CORP·Filed 2021·Granted Aug 1, 2023·0 cites·16 claims
- 4978US2021267891A1Liposomal apparatus and manufacturing methodsARBUTUS BIOPHARMA CORP·Filed 2021·Application pending·0 cites
- 5078US2020113832A1Novel lipid formulations for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2019·Application pending·0 cites
Showing the top 50 of 117 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ARBUTUS BIOPHARMA CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →